ScholarWorks@Hanyang University: Choi, Joon ho

Detailed Information

Choi, Joon ho (최준호)

COLLEGE OF MEDICINE (DEPARTMENT OF PSYCHIATRY)

Research Area

Tel 031-560-2275
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Schizophrenia:7||Antidepressant:6||Depression:5||schizophrenia:4||NCAM140:3||Guideline:3||항우울제:3||우울증:3||CREB:3||Posttraumatic growth:2||pCREB:2||Major depressive disorder:2||Depressive symptoms:2||Selfesteem:2||Mental health:2||BDI:2||Comparison:2||Suicide attempt:2||Narcissism:2||HRV:2||Fluoxetine:2||조현병:2||MMPI:2||진료지침:2||Formal thought disorder:2||Cutoff score:1||Depression symptom:1||Depressive episode:1||Difference in efficacy:1||Differential diagnosis:1||Discourse failure:1||Disorganized speech:1||Double mediated effect.:1||Drug therapy:1||EEG:1||Efficacy judgment.:1||Emotional withdrawal:1||Eye movement desensitization reprocessing:1||Forensic psychiatry:1||Formal thought disorder · Thought · Language · Gender · Schizophrenia:1||G alpha i2:1||Gs alpha:1||HSP:1||Hallucinatory behavior:1||Haloperidol:1||Hemoglobin:1||High risk of suicide:1||Homicide:1||Initial choice:1||Interpretation bias for ambiguity:1||Involuntary treatment:1||Knowledge:1||Korea:1||Korean.:1||Language disorganization:1||MK801:1||MMPI2RF:1||Medical Diseases:1||Mentally Ill patients:1||Microarray:1||Modular Architecture:1||Neurobiology:1||Neuroblastoma cells:1||Nursing Personnel:1||Pharmacological Treatment:1||Pharmacological treatment:1||Placebo:1||Portable Architecture:1||Posttraumatic stress disorders:1||Posttraumatic growth · Resilience · Assessment · Scale · Psychology · Adaptation · Clinical · Treatment:1||Practice guideline:1||Pragmatics disorder:1||Psychiatric Emergency:1||Psychiatric disorder:1||Psychometrics:1||Psychosis:1||Psychotic Depression Assessment Scale (PDAS):1||Psychotic depression (PD):1||Rat:1||Reliability and validity:1||Reliability.:1||Residual symptom:1||Resilience:1||Risperidone:1||Schizophrenia.:1||Seclusion Room:1||Sleep quality:1||Social stigma:1||Substance abuse:1||Suicidal ideation:1||Suicide ideation:1||Switching:1||Therapeutic factors:1||Tianeptine:1||Trauma:1||Treatment compliance:1||UltraShort Suicidal Ideation Scale:1||Validity:1||Violence:1||antidepressive agents:1||biopsychosocialbehavioral:1||brain activation:1||brain mapping:1||cell line:1||cerebral infarction:1||cognitive:1||cutoff score:1||detrended fluctuation analysis:1||disclosure failure:1||functional magnetic resonance imaging:1||heterogeneity:1||hippocampus:1||major depressive disorder:1||model:1||molecular chaperones:1||motor retardation:1||network analysis:1||network structure:1||neural circuitry:1||neurodevelopment:1||precision medicine:1||proteomics:1||severity ranges:1||unidimensionality:1||visual sexual stimulation:1||강화요법:1||개념:1||교체:1||동반증상:1||모듈러 건축:1||물질남용:1||미네소타 다면 인성검사 II 재구성판:1||법정신의학:1||병합요법:1||불안 증상:1||비자의치료:1||사회적 낙인:1||수면의 질:1||신경생물학:1||안정실:1||약물학적 치료:1||외상후 성장:1||외상후 성장·리질리언스·평가·척도· 심리학·적응·임상·치료:1||우울 증상:1||위약:1||이동형 건축:1||이중매개효과:1||임상경과:1||자살 고위험군:1||자살기도:1||자살사고:1||적정시점.:1||정신분열병:1||정신응급:1||정신질환자:1||주요우울장애:1||증량:1||초기선택:1||치료적 요인:1||타살:1||폭력성:1||플루세틴:1||한국형.:1||항정신병약물 부작용:1||해마:1||해석 편향:1||형식적 사고장애·사고·언어·성별·조현병:1||효과 차이:1||.:1||효과판정:1||2019 Korean Medication Algorithm for Schizophrenia:1||2019 한국형 조현병 약물치료 지침서:1||Algorithm:1||Antipsychoticsrelated Side effects:1||Anxiety symptom:1||Appropriate time:1||Arachnoid cyst:1||Attitudes:1||Augmentation.:1||BclxL:1||Bipolar disorder:1||Brief Psychiatric Rating Scale:1||Brief Psychiatric Rating scale6 (BPRS6):1||CUDOS:1||Clinical Language Disorder Rating Scale:1||Clinical Language Disorder Rating Scale (CLANG):1||Clinical course:1||Clozapineresistant:1||Coexisting symptoms:1||Combination:1||Common data model:1||Complicated appendicitis:1||Conception:1||Consensus:1||

STATISTICS: Total View :4,853,046; Today View :4,234

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE